Qube Research & Technologies (QRT)’s Novo Nordisk NVO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.4M	Sell	447,500 -233,200	-34%	-$11M	0.02%	988
2025 Q4	$34.6M	Buy	680,700 +180,000	+36%	+$9.2M	0.04%	651
2025 Q3	$27.8M	Buy	500,700 +113,500	+29%	+$6.64M	0.03%	730
2025 Q2	$26.7M	Buy	387,200 +131,600	+51%	+$8.95M	0.03%	729
2025 Q1	$17.7M	Buy	255,600 +97,700	+62%	+$8.07M	0.02%	802
2024 Q4	$13.6M	Sell	157,900 -12,000	-7%	-$1.3M	0.02%	915
2024 Q3	$20.2M	Buy	169,900 +144,600	+572%	+$19.3M	0.03%	660
2024 Q2	$3.61M	Buy	+25,300	New	+$3.35M	0.01%	1408
2024 Q1	–	Sell	-23,500	Closed	-$2.43M	–	4746
2023 Q4	$2.43M	Buy	+23,500	New	+$2.32M	﹤0.01%	1423

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 171,416 shares — an estimated $8.12M sold.

Qube Research & Technologies (QRT) first reported a position in NVO in Q1 2018 and held it in 20 quarters. The position peaked at $104M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 171,416 Novo Nordisk shares in Q1 2026, an estimated $8.12M.
Qube Research & Technologies (QRT) first reported a position in Novo Nordisk in Q1 2018 and held it in 20 quarters.
Qube Research & Technologies (QRT)'s Novo Nordisk position peaked at $104M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.